Cian Healthcare , a company currently undergoing Corporate Insolvency Resolution Process (CIRP), has announced a significant development in its ongoing insolvency proceedings. The company's resolution plan, which was previously approved by the Committee of Creditors, is now set for a crucial hearing before the National Company Law Tribunal (NCLT) Mumbai Bench.

Key Developments

• The Committee of Creditors approved Cian Healthcare's resolution plan on May 9, 2025.
• The approved plan was submitted to the NCLT Mumbai Bench-VI on May 23, 2025.
• A hearing was held before the Hon'ble NCLT on August 6, 2025.
• The next hearing for consideration and approval of the resolution plan is scheduled for August 22, 2025.

Regulatory Compliance

In compliance with Regulation 30 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015, Cian Healthcare has been keeping its stakeholders and regulatory authorities informed about the ongoing CIRP. The company's disclosures align with the SEBI Master Circular dated November 11, 2024, as amended on December 31, 2024.

Management Statement

Roshen Chordiya, the Resolution Professional for Cian Healthcare Limited, stated in the company's BSE filing, "We shall continue to keep all stakeholders and regulatory authorities abreast of further material developments in this regard."

Company Background

Cian Healthcare Limited, an ISO 9001:2015 & WHO GMP Certified company, operates from its registered office in Pune and has a manufacturing facility in Uttarakhand.

As the insolvency resolution process progresses, stakeholders and industry observers will be closely watching the outcome of the August 22 hearing, which could potentially determine the future course for Cian Healthcare Limited.

Cian Healthcare Limited has provided an update on its ongoing Corporate Insolvency Resolution Process (CIRP). The company, currently under insolvency proceedings, announced that a crucial hearing was held at the National Company Law Tribunal (NCLT), Mumbai Bench-VI.

Key Developments

• Resolution Plan Approval: The Committee of Creditors had previously approved a Resolution Plan in their meeting on May 9, 2025.
• NCLT Submission: The approved Resolution Plan was subsequently submitted to the NCLT on May 23, 2025.
• Next Hearing: The NCLT has scheduled the next hearing for consideration and approval of the resolution plan on August 6, 2025.

Corporate Disclosure

In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cian Healthcare Limited has been keeping its stakeholders informed about the ongoing CIRP.

The company's Resolution Professional, Roshen Chordiya, confirmed these developments in a regulatory filing dated August 5, 2025. The filing also referenced earlier intimations, including one dated July 1, 2025, which had initially disclosed the approval of the Resolution Plan by the Committee of Creditors.

Continued Transparency

Cian Healthcare has assured its stakeholders that it will continue to provide updates on any material developments in the insolvency resolution process. This commitment to transparency aligns with the regulatory requirements and aims to keep all interested parties, including investors and creditors, well-informed about the company's status.

The outcome of the August 6 hearing could potentially determine the future course of Cian Healthcare Limited, as the NCLT considers the approval of the submitted resolution plan.

Investors and stakeholders are advised to monitor official communications from the company and regulatory bodies for further updates on this matter.